Geoffrey Ian Hackett

5PUBLICATIONS
19CO-AUTHORS
Ecosystem services (incl. pollination)PharmacogenomicsToxicology (incl. clinical toxicology)Medical biotechnology diagnostics (incl. biosensors)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 20, 2026
Evidence for the Additional Health Benefits Associated with Phosphodiesterase 5 Inhibitors when Used for Treating Erectile Dysfunction, with a Focus on Prostate Cancer Patients and Other Associated Conditions.

Alexandra Naranjo, Geoffrey Ian Hackett, Sophie Smith

|Jan 09, 2026
The Role of Daily Phosphodiesterase 5 Inhibitors in the Management of Diabetic Neuropathy-The Importance of a Multidisciplinary Approach.

Geoff Ian Hackett

|Mar 04, 2025
British Society for Sexual Medicine (BSSM) Position Statement on Premature Ejaculation.

Geoff Ian Hackett, Mike Kirby, Patricia Schartau

|Mar 06, 2023
The British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with Statements for Practice.

Geoffrey Hackett, Michael Kirby, Rowland W Rees

|Oct 06, 2022
Examining Male Predominance of Severe COVID-19 Outcomes: A Systematic Review.

David K Twitchell, Michael B Christensen, Geoffrey Hackett

Pageof 1

Frequent Collaborators

2 joint publications

Mike Kirby

2 joint publications

Nick Ossei-Gerning

2 joint publications

Janine David

1 joint publications

Patricia Schartau